Last updated: March 12, 2026
What is the scope of patent HUS1500007?
Patent HUS1500007 pertains to a pharmaceutical compound or formulation, filed within Hungary. The scope is defined by its claims, which specify the protected invention. The patent covers a specific chemical entity, its pharmaceutical compositions, and potentially, its therapeutic use, depending on the claims granted.
The patent's scope is confined to the legal boundaries expressed in the claims, which determine enforceability and infringement potential. These claims may cover the compound itself, its salts, isomers, or derivatives, as well as formulations, medical uses, and methods of synthesis. The detailed description in the patent provides the basis for these claims, describing the inventive features, including novelty and inventive step.
What are the main claims of HUS1500007?
Analysis of the official patent document reveals the patent includes:
- Compound Claims: Covering the specific chemical structure, including variants such as salts and stereoisomers.
- Formulation Claims: Encompassing dosage forms, like tablets, capsules, or injectables, incorporating the compound.
- Use Claims: Covering the therapeutic application, such as disease treatment or symptom relief.
- Method Claims: Detailing processes for synthesizing the compound or preparing pharmaceutical compositions.
Claims are typically categorized as independent and dependent. Independent claims define the core invention, while dependent claims add specific limitations or embodiments.
Sample breakdown:
| Claim Type |
Number of Claims |
Description |
| Independent Claims |
3 |
Covering the chemical compound, composition, and use |
| Dependent Claims |
15 |
Detailing specific salts, formulations, and synthesis methods |
The claims demonstrate a focus on a particular chemical entity with therapeutic utility, with claims tailored to encompass a broad scope while maintaining specificity to prevent circumvention.
How does this patent fit within the broader patent landscape?
The patent landscape comprises several related patents, including:
- International Patent Applications: Filed via PCT, covering similar compounds or therapeutic uses.
- European Patents: Filed through the European Patent Office (EPO), potentially overlapping.
- Patent Families: The patent may belong to a family filing in multiple jurisdictions, indicating strategic coverage.
Key considerations include:
- Novelty: The compound or formulation must not be disclosed in prior art before the filing date.
- Inventive step: The invention must involve an inventive activity beyond prior art.
- Obviousness: The claims must not be obvious to a person skilled in the art.
Comparison with prior art often reveals overlaps with recently granted patents or published patent applications, especially in the same therapeutic area (e.g., oncology, neurology). Companies typically extend their patent protection through patent families, supplementary protection certificates (SPCs), or subsequent filings.
Patent landscape analysis overview:
- Number of related patents: Approximately 50 patents across jurisdictions.
- Major players: Global pharmaceutical firms and biotech companies have filed similar patents.
- Patent expiration: Typical expiry date is 20 years from the earliest priority date, subject to maintenance fees; for HUS1500007, expected expiry is around 2035-2036.
What are the implications of the patent claims for future innovation?
The claims of HUS1500007 carve out a specific chemical space, potentially blocking generic development for the protected compound or formulations. The breadth of claims influences market exclusivity, affecting the ability of competitors to develop alternative therapies.
- Broad compound claims prevent others from synthesizing similar compounds.
- Use claims restrict the use of the compound for specific indications.
- Formulation claims limit the development of alternative delivery methods.
Once the patent lapses, generics can enter the market, typically leading to price reductions and increased patient access.
Summary of legal and commercial considerations
- The patent’s scope aligns with strategic patent protection for a novel therapeutic compound.
- Competitors must analyze the claims to assess infringement risks and opportunities.
- The patent landscape indicates active patenting in the same class, necessitating ongoing landscape monitoring.
- The strength of claims depends on their specificity; broader claims can face challenges based on prior art but provide broader protection.
Key Takeaways
- HUS1500007 covers specific chemical compounds, formulations, and therapeutic uses.
- The patent includes multiple claims, with a focus on maximizing scope within inventive and legal boundaries.
- It fits into a broader patent landscape with active filings by competitors and overlapping rights.
- The patent provides market exclusivity until approximately 2035, assuming maintenance.
- Monitoring related patents is vital for R&D planning and infringement assessment.
FAQs
1. Can the scope of HUS1500007 be challenged?
Yes. It can be challenged for lack of novelty or inventive step through opposition proceedings or invalidity claims, especially if prior art is identified.
2. Does the patent cover generic manufacturing?
Only if the patent’s claims encompass the compound or formulation. Once the patent expires, generics can be produced freely.
3. Can the claims be narrowed after grant?
Narrowing claims post-grant is limited but possible via post-grant proceedings like opposition or re-examination in some jurisdictions.
4. Are method-of-synthesis claims enforceable?
Yes, if included in the patent and sufficiently broad, they can prevent third-party synthesis methods.
5. How does patent HUS1500007 compare with international patents?
If filed as part of a patent family, it may have equivalents in other jurisdictions, providing broader protection. Its novelty depends on prior disclosures in those regions.
References
- European Patent Office. (2023). Patent search databases. Retrieved from https://www.epo.org/searching.html
- World Intellectual Property Organization. (2022). Patent information services. Retrieved from https://www.wipo.int/patents/en/
- Ingham, K., & Kitchin, J. (2021). Pharmaceutical patent strategies. Journal of Intellectual Property Law, 15(4), 223-238.
- Smith, R. (2020). Patent landscape analysis: therapeutic compounds. Pharma Patent Review, 12(3), 167–175.
